RAPGEF4

RAPGEF4 Full Name

Rap guanine nucleotide exchange factor (GEF) 4

RAPGEF4 Introduction

RAPGEF4, also known as Epac2 (exchange protein directly activated by cAMP 2), is a cyclic-AMP-activated guanine nucleotide exchange factor that activates the small G protein Rap in response to hormonal and neurotransmitter signals. The protein is highly expressed in pancreatic beta cells, the adrenal medulla, the pituitary, and several brain regions including the hippocampus and hypothalamus, where it mediates many of cAMP's effects that are independent of protein kinase A. Alternative promoters produce a widely expressed Epac2A isoform and a shorter, beta-cell-enriched Epac2B isoform that lacks the first cyclic-nucleotide-binding domain.

Figure 1. The structure of RAPGEF4.

cAMP-Dependent Activation of Rap GTPases
Each Epac2 molecule carries two cyclic-nucleotide-binding (CNB) domains; binding of cAMP to the high-affinity CNB-B relieves an autoinhibitory interaction with the REM and CDC25 homology domains, allowing Epac2 to catalyze GDP-to-GTP exchange on Rap1 and Rap2. Activated Rap in turn engages a variety of effectors including RapGAPs, RASSF family proteins, and phospholipase C epsilon, integrating cAMP signals with Ras-related MAPK cascades. In pancreatic beta cells, Epac2 responds to glucose-elevated cAMP to amplify the second phase of insulin secretion through PKC-dependent and PKC-independent mechanisms, while in neurons it couples cAMP rises to spine remodeling and long-term depression.

Metabolic Disease, Pain, and Cancer
Genetic studies in rodents have shown that loss of Epac2 impairs glucose-stimulated insulin secretion, and human GWAS link RAPGEF4 variants to type 2 diabetes risk and to glycemic responses to sulfonylureas. In the pain pathway, Epac2 in sensory neurons contributes to the maintenance of mechanical hypersensitivity, and Epac2 inhibitors are being explored as non-opioid analgesics. Dysregulated Epac2/Rap signaling has been reported in several cancers, including pancreatic and colorectal tumors, where it influences cell proliferation, migration, and chemoresistance, prompting interest in targeting the Epac2–Rap interface for anticancer therapy.

Alternate Names for RAPGEF4

RAPGEF4; Rap guanine nucleotide exchange factor (GEF) 4; 2; EPAC; CGEF2; EPAC2; EPAC 2; Nbla00496; CAMP-GEFII; rap guanine nucleotide exchange factor 4